The heart is arguably one of the most critical organs within the human body, pumping oxygen-rich blood throughout. While ...

EBR Systems Inc. raised AU$55.9 million (US$36 million) to commercialize its Wise cardiac resynchronization therapy system ...

A 46-year-old woman with type 1 myotonic dystrophy (DM1) presented to the emergency department with dyspnea and palpitations.

Introduction: Shoulder pain and disability ipsilateral to the implant site is a common complication of cardiac rhythm device ... that a self-directed physical therapy program, geared toward ...

Defibrillation should be used during a life threatening arrhythmia or if the heart has stopped beating altogether (cardiac arrest). To prepare, you’ll need to determine which medications you can ...

Therapy can be expensive, even with online platforms. Truly free online therapy options are rare, and most free therapy options use trained volunteer listeners over fully qualified therapists.

Infant With Rare, Incurable Disease Is First to Successfully Receive Personalized Gene Therapy Treatment May 15, 2025 — A research team has developed and safely delivered a personalized gene ...

Nanoscope Therapeutics is on the brink of filing for FDA approval of what could be the first gene therapy for incurable eye disease retinitis pigmentosa (RP) that can be used regardless of ...

BACKGROUND: Dilated cardiomyopathy (DCM) is substantially influenced by genetic factors. Sarcomere function is intricately associated with other organelles, particularly the reciprocal regulation ...

The EMA has called a temporary halt to a phase 2 trial of Sarepta's Roche-partnered Duchenne muscular dystrophy (DMD) gene therapy Elevidys in the wake of the death of a patient who received the ...

May 22, 2025 — When the workload on the heart increases, the ventricular wall may thicken too, known as cardiac hypertrophy. This is an adaptive response that reduces pressure on the heart and ...